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Fragile X syndrome (FXS), the leading monogenic
cause of intellectual disability and autism, results
from loss of function of the RNA-binding protein
FMRP. Here, we show that FMRP regulates transla-
tion of neuronal nitric oxide synthase 1 (NOS1) in
the developing human neocortex. Whereas NOS1
mRNA is widely expressed, NOS1 protein is tran-
siently coexpressedwith FMRPduringearly synapto-
genesis in layer- and region-specific pyramidal
neurons. These include midfetal layer 5 subcortically
projecting neurons arranged into alternating columns
in the prospective Broca’s area and orofacial motor
cortex. Human NOS1 translation is activated by
FMRP via interactions with coding region binding
motifs absent from mouse Nos1 mRNA, which is
expressed in mouse pyramidal neurons, but not
efficiently translated. Correspondingly, neocortical
NOS1 protein levels are severely reduced in devel-
oping human FXS cases, but not FMRP-deficient
mice. Thus, alterations in FMRP posttranscriptional
regulation of NOS1 in developing neocortical circuits
may contribute to cognitive dysfunction in FXS.
INTRODUCTION
The development of neural circuits is a precisely regulated
process susceptible to genetic alterations that can lead to disor-ders affecting the most distinctively human aspects of cognition,
including speech and language, theory of mind, and complex
social behavior (Geschwind and Levitt, 2007; Lui et al., 2011;
Ramocki and Zoghbi, 2008; State, 2010; Walsh et al., 2008).
One such disorder, fragile X syndrome (FXS), is the leading
inherited cause of intellectual disability and is often accompa-
nied by autistic-like features, aggression, attention deficits,
and delays in speech and language development (Abbeduto
et al., 2007; Rogers et al., 2001; Willemsen et al., 2011). FXS is
caused by loss of function of the FMR1 gene, which encodes
an RNA-binding protein (FMRP) involved in mRNA localization,
stability, and translation (Ashley et al., 1993; Bagni and
Greenough, 2005; Bassell and Warren, 2008; Zalfa et al.,
2007). Many FMRP mRNA targets function in synaptic develop-
ment and plasticity (Brown et al., 2001; Darnell et al., 2011).
Concordantly, Fmr1-deficient mice show neural deficits also
found in patients with FXS (The Dutch-Belgian Fragile X Consor-
tium, 1994). However, FMRP target mRNAs and their role in
human neurodevelopment are not as well understood.
The study of human FMRP function may also provide insights
into the molecular mechanisms and neural circuits affected in
autism spectrum disorders (ASDs), which are highly comorbid
with FXS (Rogers et al., 2001). ASDs are a group of complex
developmental syndromes characterized by impairments in
social communication and language development, and repetitive
behaviors. Multiple lines of evidence point to the dysfunction of
neocortical circuits involved in social, emotional, and language
processing in ASDs (Geschwind and Levitt, 2007; State, 2010;
Walsh et al., 2008). Although no overt neuroanatomical alter-
ations have been linked to the autistic brain, there is emerging
evidence of abnormal organization of cortical minicolumnsCell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc. 899
(Casanova et al., 2002; Peters, 2010), which are composed of
vertically arranged neurons connected into a local network
and thought to originate from developmental radial units
(Mountcastle, 1997; Rakic, 1988). Whether the molecular mech-
anisms altered in ASDs are associated with the development of
specific human cortical circuits, including minicolumns, remains
unknown.
Here, we report that FMRP binds human neuronal nitric oxide
synthase 1 (NOS1, also known as nNOS) mRNA and increases its
translation in the developing neocortex in a species-dependent
manner. NOS1 produces the gaseous signaling molecule nitric
oxide (NO), which plays important roles in the development
and function of the nervous system (Bredt and Snyder, 1994;
Garthwaite, 2008). Our study of NOS1 posttranscriptional regu-
lation was instigated by our observation of a marked discrep-
ancy between the midfetal human neocortex expression
patterns of NOS1 mRNA, which is widespread, and NOS1
protein, which is restricted to layer- and region-specific subpop-
ulations of pyramidal neurons. These include layer 5 (L5)
subcortically-projecting neurons with an alternating minicolum-
nar arrangement in the frontoparietal operculum (FOp). The
FOp encompasses the prospective Broca’s area and orofacial
motor cortex, regions involved in speech production and
language comprehension (Keller et al., 2009). After our screen
for RNA-binding proteins revealed that FMRP is abundantly
bound to human NOS1 mRNA, we found that FMRP interacts
with sequences in the NOS1-coding region that contain
G-quartet (GQ) motifs and leads to increased NOS1 protein
expression. These motifs are absent from mouse Nos1 mRNA,
and replacing the GQ-containing region of human NOS1 with
the mouse orthologous sequence abrogates FMRP-dependent
activation of translation. Concordantly, neocortical NOS1
protein levels are dramatically reduced in human FXS, but not
Fmr1-deficient mice. Thus, we identified a species-dependent
posttranscriptional regulation of human NOS1 by FMRP in
specific neocortical circuits during column development and
synaptogenesis, and showed it to be altered in FXS.
RESULTS
NOS1 Protein Is Transiently Expressed in Developing
Human Pyramidal Neurons
The current research stems from our unexpected observation
that strong NADPH-diaphorase (NADPH-d) activity, a reliable
histoenzymatic marker of NOS (Dawson et al., 1991; Hope
et al., 1991), is transiently present in subpopulations of pyramidal
neurons in the developing human neocortex (Sestan and
Kostovic, 1994), in addition to its previously reported localization
to interneurons and cortical plate (CP) neuropil (Fertuzinhos
et al., 2009; Judas et al., 1999). Our comprehensive analysis of
pre- and postnatal postmortem brains ranging from 8 postcon-
ceptional weeks (PCW) to adulthood identified transient expres-
sion of NOS1/NADPH-d in two layer- and region-specific popu-
lations of pyramidal neurons with a predominant localization to
somata and apical dendrites (Figures 1A–1C; see Figure S1A
available online). Specifically, morphologically immature pyra-
midal neurons expressing NOS1 were present in the middle of
the CP corresponding to the future L5 exclusively in the ventro-900 Cell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc.lateral frontal cortex of the FOp and the dorsal part of the anterior
insula starting around 15 PCW. One week later, NOS1+ pyra-
midal neurons were also found in the anterior cingulate cortex
(ACC) and adjacent dorsolateral frontoparietal cortex in the
upper CP corresponding to the future L2 and L3. NOS1 expres-
sion in both of these regions was also temporally regulated. The
ACC L2/L3 expression of NOS1 was maintained at high levels
throughout the late fetal ages, and decreased during early
infancy (Figures 1B and S1A; data not shown). In contrast, L5
expression of NOS1 occurred in two waves. First, the L5 expres-
sion was restricted to the FOp, and started at 15 PCW, peaked at
18–20 PCW, andwas rapidly downregulated at approximately 23
PCW, after which a small number of NOS1+ pyramidal neurons
were present in the ventral part of the anterior insula. Second,
sparse pyramidal NOS1 expression was present throughout
neocortical L5 in the weeks immediately prior to birth and was
progressively downregulated after birth (Figures 1B and S1A;
data not shown). Thus, in developing pyramidal neurons,
NOS1 expression is precisely regulated, exhibiting temporal,
laminar, and regional specificity.
Fetal L5 NOS1+ Pyramidal Neurons Form Alternating
Columns
Further analysis of themidfetal FOpL5NOS1+pyramidal neurons
revealed that they were arranged vertically into alternating arrays
of intensely (NOS1+) and lightly (NOS1) stained pyramidal
neurons (Figures 1A and 1C) resembling previously described
ontogenetic columns (Rakic, 1988). In contrast the ACC L2/L3
NOS1+ pyramidal neurons were more densely distributed (Fig-
ure 1D; FOp L5, 67.86 ± 5.66 cells per 1,000 mm2; ACC L3,
178.57 ± 27.95 cells per 1,000 mm2; p = 4.123 105) and lacked
this alternating columnar arrangement (Figure 1E; nearest
neighbor distance between cell clusters: FOp L5, 27.87 ±
5.26 mm; ACC L3, 15.75 ± 4.68 mm; p = 4.243 109). In contrast
to midgestation, perinatal NOS1+ L5 neurons did not exhibit
columnar organization (Figure S1A).
Because the FOp is structurally and functionally lateralized
(Keller et al., 2009), we investigated whether L5 NOS1+ columns
exhibited left-right asymmetry in two whole midfetal brains (18
and 20 PCW). Serial reconstruction confirmed the two separate
domains of NOS1+ pyramidal neurons in the FOp and ACC of
both hemispheres (Figures 1F and S1B) and provided approxi-
mate total numbers of FOp NOS1+ columns (18 PCW: 41,380;
and 20 PCW: 45,150). Although the number of NOS1+ columns
was not significantly different between the left and right hemi-
spheres (p = 0.569), the distribution of NOS1+ columns showed
an asymmetric trend, peaking more rostrally in the right hemi-
sphere, in both brains. Thus, the columnar organization of
NOS1+ neurons in the midfetal FOp L5 is bilaterally present.
Molecular and Projectional Identity of NOS1+ Pyramidal
Neurons
To molecularly characterize the identity of NOS1+ neurons, we
examined their expression of neuronal subtype markers. In the
midfetal FOp L5, markers of subcortically-projecting pyramidal
neurons, BCL11B (CTIP2) and FEZF2 (FEZL, ZFP312) (Chen
et al., 2005; Kwan et al., 2008; Leone et al., 2008; Molyneaux
et al., 2007), were selectively coexpressed by L5 NOS1+
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Figure 1. Spatiotemporal Dynamics of NOS1 Expression in Pyramidal Neurons of the Human Neocortex
(A) NADPH-d histochemistry at 18 PCW revealed intensely labeled pyramidal neurons in ACC L3 and FOp L5, where stained neurons were arranged into
alternating vertical columns (open arrow). Interneurons (arrowhead) and blood vessels (asterisks) were also labeled. Boxes represent the 25th, 50th, and 75th
percentiles.
(B) Schematic summary of the spatiotemporal dynamics of NOS1/NADPH-d staining in pyramidal neurons of L2/L3 (green) and L5 (red) in the developing and
adult human neocortex.
(C) NOS1 immunohistochemistry of radial and tangential sections at 20 PCW. NOS1+ pyramidal neurons exhibited a clear columnar organization in FOp L5, but
not ACC L3.
(D and E) Analysis of cell density (D) and cluster spacing (E) revealed that NOS1+ neurons in FOp L5 were significantly distinct in cytoarchitectonic organization
from those in ACC L3. *p < 0.05. Boxes represent the 25th, 50th, and 75th percentiles. Error bars represent the 5th and 95th percentiles of 30 measurements.
(F) Serial section analysis of NADPH-d+ L5 columns in two brains at 18 and 20 PCW. NADPH-d+ columns were present bilaterally.
See also Figure S1.neurons, forming an alternating columnar pattern identical to that
of NOS1 (Figures 2A, 2B, and 2D). NOS1+ neurons also coex-
pressed FOXP2 (Figure 2E), a gene altered in a developmental
disorder characterized by impaired speech and linguistic deficits
(Lai et al., 2001). In contrast, SATB2, amarker of upper-layer cor-
ticocortical pyramidal neurons (Britanova et al., 2008), was
highly expressed in NOS1, but not NOS1+, neurons (Figures
2A and 2B), suggesting that NOS1 neurons were later born
and likely migrating in between L5 NOS1+ columns to the upper
layers. Consistent with this, we observed vimentin (VIM)-positive
radial glial fibers in between but not within NOS1+ columns (Fig-
ure S2A). This suggests that glial-guided migration of upper-
layer neurons occurs via corridors formed between L5 neuronal
columns. In the ACC, all L2/L3 NOS1+ neurons coexpressed
SATB2 (Figure S2B), confirming their upper-layer identity and
distinction from the FOp L5 NOS1+ neurons.
To examine whether the midfetal pyramidal neurons of diverse
subtypes have distinct cytoarchitectonic arrangements, we first
measured the nearest neighbor ratio (NNR) and total path length
ratio (TPLR) (Buxhoeveden et al., 1996) of NOS1+ and NOS1 L5
neurons in the 20 PCW FOp (Figure 2C). This confirmed thatNOS1+ L5 neurons were significantly closer to being perfectly
columnar (1.0) compared to NOS1 L5 neurons, as determined
by both NNR (NOS1+, 1.145 ± 0.146; NOS1, 1.528 ± 0.202;
p = 2.97 3 105) and TPLR (NOS1+, 1.122 ± 0.077; NOS1,
1.740 ± 0.369; p = 2.41 3 103). Next, we retrogradely traced
projection neurons in a postmortem 20 PCW brain. We labeled
subcortical projection neurons with Fast DiI inserted into the
internal capsule and corticocortical projection neurons with
Fast DiA inserted into the corpus callosum (Figure 2H). DiI-
labeled subcortical projection neurons in the FOp formed
columns similar in organization to the NOS1+ columns (Figure 2I).
In contrast, DiA-labeled callosal neurons in the ACC did not
exhibit columnar organization (Figure 2J). Collectively, these
results indicate that FOp NOS1+ neurons exhibit the columnar
organization and molecular identity of postmigratory L5 sub-
cortically-projecting neurons.
Transient NOS1 Expression in Pyramidal Neurons
Is Concomitant with Early Synaptogenesis
Previous studies have shown that significant neocortical synap-
togenesis starts during midgestation (Molliver et al., 1973).Cell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc. 901
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Figure 2. Molecular, Structural, and Axonal Connectivity Analyses of L5 NOS1+ Columns in the Midfetal Human FOp
(A and B) Triple-immunofluorescent staining for NOS1 (green), BCL11B (blue), a marker of L5 subcortically-projecting neurons, and SATB2 (red), a marker of
upper-layer corticocortical projection neurons, in 20 PCW FOp L5. NOS1+ and BCL11B+ pyramidal neurons formed alternating columns (outlined) separated by
clusters of SATB2+ neurons.
(C) Analysis of columnarity in FOp L5 neurons. NOS1+ neurons were significantly more columnar in organization compared to NOS1 neurons. *p < 0.05. Boxes
represent the 25th, 50th, and 75th percentiles. Error bars represent the 5th and 95th percentiles of 30 measurements. diff, difference.
(D) NOS1 immunostaining (brown) and FEZF2 in situ hybridization (blue) of FOp L5 at 18 PCW. NOS1+ neurons coexpressed FEZF2 (open arrowheads).
(E–G) Immunofluorescent staining for NOS1 (green) and FOXP2, SYP, or FOS (red in E–G). NOS1+ neurons coexpressed FOXP2 and FOS (arrowheads in E and G)
and were encircled by SYP puncta (arrowheads in F).
(H–J) Retrograde axonal tracing at 20 PCW. Retrograde travel of Fast DiI inserted into dorsal internal capsule (red arrowhead) and Fast DiA inserted into the
corpus callosum (green arrowhead) were examined after 7 months in incubation. In the FOp L5 (I), DiI-labeled subcortical projection neurons formed columns
similar to those composed of NOS1+ neurons. In the ACC (J), DiA-labeled corticocortical projection neurons did not exhibit obvious columnar organization. White
box in (I) represents area enlarged in inset.
See also Figure S2.Consistent with the possibility that NOS1 expression is
associated with synaptogenesis, we found presynaptic
synaptophysin (SYP) puncta encircling the cell membrane of
FOp NOS1+ L5 neurons at the soma and apical dendrite (Fig-
ure 2F). Our pre-embedding NOS1 immuno-EM in the 18
and 20 PCW FOp, however, revealed only sparse mature
synapses in the CP (Figures S2C and S2D), suggesting that
the majority of SYP+ puncta on L5 NOS1+ columns were
immature terminals. Concordantly, immature synapses that
have not yet become electron dense or accumulated vesicles
and nonsynaptic contacts were observed in L5 and on NOS1+
dendrites (Figures S2E–S2H). Interestingly, FOS (C-FOS),
a marker of recent neuronal activity, was expressed by virtually
all NOS1+ columnar neurons and was mostly absent from
NOS1 intercolumnar neurons in the 20 PCW FOp (Figure 2G),
suggesting that NOS1+ L5 neurons may be active. Together,
these findings suggest that the expression of NOS1 in L5 FOp
neurons is concomitant with early synaptogenesis and neuronal
activity.902 Cell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc.Cross-Species Comparison of Neocortical NOS1
Expression
To determine whether the spatiotemporal expression pattern of
NOS1 exhibits species differences, we examined NADPH-
d/NOS1 expression in the gyrated macaque monkey neocortex
and lissencephalic mouse neocortex (Figure 3; data not shown).
In the macaque, NADPH-d+ pyramidal neurons were present in
L2/L3 of the ACC and adjacent frontoparietal regions, starting
as early as embryonic day (E) 62, an age equivalent to human
midgestation (Kostovic and Rakic, 1990), and persisting until
the late fetal period (Figures 3B and S3; data not shown).
NADPH-d+ pyramidal neurons were present in L5 columns of
the FOp and adjacent regions (Figures 3B and 3C), starting as
early as E73, peaking near E82, and persisting until at least
E113 (Figures 3B and S3; data not shown). Consistent with
previous studies, our analyses of the mouse neocortex from
E18.5 to P14, a period equivalent to human midfetal to early
postnatal development, revealed that intense NADPH-d activity
was present exclusively in interneurons and neuropil (Figure 3A;
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Figure 3. Comparative Analysis of NADPH-
d Activity in Mouse, Macaque, and Human
Neocortex at Equivalent Developmental
Ages
In the P4 mouse ACC and lateral frontal cortex (A),
intense NADPH-d staining was restricted to inter-
neurons, with neuropil staining in ACC L2/L3. In
the E73macaque neocortex (B), intense NADPH-d
activity was present in ACC L2/L3 pyramidal
neurons similar to those labeled in the human 18
PCWACC (C). In the macaque FOp, NADPH-d+ L5
pyramidal neurons were arranged into vertical
columns similar in organization to the human
FOp columns (C). Strong interneuronal and weak
neuropil NADPH-d staining was present in all
cortical areas in mouse, macaque, and human
neocortex. See also Figure S3.data not shown), indicating that pyramidal expression of NOS1 is
species dependent.
Discordant NOS1 mRNA and Protein Expression
Patterns in the Fetal Neocortex
To examine the expression pattern of NOS1 mRNA, adjacent
tissue sections of the midfetal neocortex were analyzed with
NOS1 in situ hybridization, NADPH-d, and NOS1 immunostain-
ing (Figure 4A). Surprisingly, NOS1 mRNA was abundantly and
widely present in the CP in all cortical layers and regions exam-
ined, including the great majority of pyramidal neurons that
did not express NOS1 protein. This striking difference between
the highly restricted NOS1 protein and widespread NOS1
mRNA expression suggests that NOS1 is posttranscriptionally
regulated.
Remarkably, Nos1 mRNA was also abundantly and widely
expressed in the early postnatal mouse neocortex (Figure 4B).
Pyramidal expression of mouse Nos1 mRNA was confirmed by
quantitative RT-PCR of fluorescently sorted pyramidal neurons
fate mapped in mice doubly transgenic for Emx1-Cre and
a CRE-responsive Gfp (CAG-Cat-Gfp) (Figure 4C). Therefore,
whereas NOS1 mRNA is expressed in pyramidal neurons of
both human and mouse neocortex, its efficient translation into
NOS1 protein occurs in subpopulations of human, but not
mouse, pyramidal neurons. This indicates that pyramidal NOS1
expression is driven by species-dependent posttranscriptional
regulation.
NOS1 mRNA Associates with FMRP in Human Fetal
Neocortex
To identify potential NOS1 mRNA-binding proteins, we used
immobilized full-length human NOS1 mRNA to pull down candi-
date proteins from the human frontal CP at 20 and 21 PCW.
To facilitate the isolation of sequence-dependent RNA-binding
proteins, we used three negative control RNAs (GAPDH,
EGFP, and NeoR). NOS1 mRNA-interacting proteins showed
a distinct enrichment at a molecular weight of approximately75 kDa (Figure 5A). To identify the protein present in this band,
we analyzed our human brain transcriptome data set (http://
www.humanbraintranscriptome.org; Johnson et al., 2009;
Kang et al., 2011) for RNA-binding proteins near 75 kDa that
are expressed in the midfetal frontal neocortex. Analysis of
four candidates (FMRP, FXR1, CPEB3, and EIF2C2) by immuno-
blotting of pulled-down proteins revealed that FMRP, but not the
others, was strongly and specifically associated with NOS1
mRNA (Figures 5A and S4A). The presence of FMRP in this
NOS1-enriched band was confirmed by mass spectrometry
(data not shown), which also revealed the putative presence of
PABPC4, a poly-adenylate-binding protein, and HSPA8, a chap-
erone protein. Double-immunofluorescent staining showed that
FMRP was highly coexpressed in NOS1+ pyramidal neurons in
the midfetal FOp and ACC (Figures 5B and S4B). Subcellularly,
FMRP and NOS1 colocalized to the soma and apical dendrite.
Interestingly, most NOS1+ interneurons in the SP and CP did
not express FMRP at high levels during midgestation. Together,
these results suggest a potential role of FMRP in the posttran-
scriptional regulation ofNOS1 in fetal human pyramidal neurons.
Species Differences in FMRP-NOS1 mRNA Association
in the Developing Neocortex
To confirm the putative FMRP-NOS1mRNA interaction, we per-
formed RNA-binding protein immunoprecipitation (RIP) using
21 PCW frontal CP lysate. RNAs coimmunoprecipitated with
FMRP were analyzed using quantitative RT-PCR (Figure 5C).
Compared to rabbit immunoglobulin (IgG) control, anti-FMRP
antibodies immunoprecipitated 6.8- ± 0.8-fold more NOS1
mRNA, a level of enrichment similar to MAP1B mRNA (7.1- ±
0.6-fold), a well known target of FMRP (Darnell et al., 2011),
and significantly higher than GAPDH mRNA (1.5- ± 0.4-fold),
a negative control. In contrast in the early postnatal mouse
neocortex (Figure 5D), Nos1 mRNA was enriched only 2.7- ±
0.3-fold by anti-FMRP immunoprecipitation, markedly lower
than the 8.6- ± 0.5-fold enrichment for Map1b mRNA and
comparable to Gapdh mRNA (2.0- ± 0.1-fold). Consistent withCell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc. 903
MZ
SP
CP
FEZF2 mRNANissl stain NOS1 protein NADPH-diaphoraseNOS1 mRNA
* * * * * * * * * * * * *
FO
p
A
C
C
D
o
rs
o
la
te
ra
l P
FC
L5
A
B
50 μm
Nos1 mRNA NOS1 protein NADPH-diaphorase
Emx1
lineage
Non-Emx1
lineage
1.6
0.8
0   
  N
o
rm
al
iz
ed
N
os
1 
m
RN
A
 le
ve
ls
P3
 m
o
u
se
 n
eo
co
rt
ex
FACS + Nos1 qRT-PCRC
SP
MZ
L5
Figure 4. Discordant NOS1 mRNA and NOS1 Protein Expression Patterns in the Developing Human and Mouse Neocortex
(A) Nissl staining, FEZF2 and NOS1 in situ hybridization, NOS1 immunohistochemistry, and NADPH-d histochemistry in adjacent sections from 18 PCW FOp,
ACC, and dorsal lateral prefrontal cortex (PFC). NOS1 mRNA was abundantly present in all cortical regions and layers examined. Intense NOS1 and NADPH-
d labeling in L5 pyramidal columns (asterisks) were present in the FOp. In all examined cortical regions, NOS1 and NADPH-d were present in interneurons (open
arrowheads) and neuropil. Red boxes represent areas enlarged.
(B)Nos1 in situ hybridization, NOS1, andNADPH-d staining in adjacent sections fromP3mouse frontal neocortex.Nos1mRNAwaswidely present; intense NOS1
and NADPH-d stainings were exclusively present in interneurons (open arrowheads). Neuropil was weakly stained. MZ, marginal zone; SP, subplate.
(C) Pyramidal neurons of the Emx1 lineage were isolated from the P3 mouse neocortex by fluorescent cell sorting (FACS) and analyzed by quantitative (q)
RT-PCR. Nos1 mRNA was abundantly present in pyramidal neurons. Error bars represent the 5th and 95th percentiles of four measurements.this, Nos1 was absent from the FMRP targets identified in
a recent, comprehensive HITS-CLIP analysis of the mouse brain
(Darnell et al., 2011). Thus, FMRP strongly associates with
human but not mouseNOS1mRNA in the developing neocortex,
suggesting that FMRPmay underlie species differences inNOS1
translation.
FMRP Binds GQ-Containing Sequences in the Human
NOS1-Coding Region
FMRP can interact with specific mRNA sequences including GQ
structures (Darnell et al., 2001; Schaeffer et al., 2001) and poly-
uridine stretches (Chen et al., 2003). Analysis of human NOS1
mRNA revealed three putative GQ motifs and six poly-uridine
stretches (Figure 6A). RNA pull-down assays from 21 PCW904 Cell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc.frontal CP lysate revealed that FMRP had strong affinity for
each of the two NOS1-coding region GQs (GQ1 and GQ2), but
not GQ3 or the U-rich regions (UR1–UR6) (Figure 6B). To confirm
this, we synthesized a fragment of RNA representing both GQ1
and GQ2 and performed an electrophoretic mobility shift assay
(EMSA; Figure 6C). In the presence of FMRP, this RNA exhibited
a significant shift that was abolished by the addition of excess
nonbiotinylated ‘‘cold’’ RNA or a neutralizing FMRP antibody.
To determine whether human GQ1 and GQ2 form RNA G-quad-
ruplex structures, we used a reverse-transcription termination
assay (Figure 6D). Reverse-transcriptase activity pauses at sites
of GQ structures in a cation-dependent manner (Schaeffer et al.,
2001). Reverse transcription from both GQ1 and GQ2 RNA
exhibited a significant pause at the expected GQ site in the
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Figure 5. FMRP Binds NOS1 mRNA in the Human Fetal Neocortex
(A) Proteins eluted from an mRNA pull-down assay using lysates of a 21 PCW human neocortex were analyzed by silver staining and immunoblotting. NOS1, but
not control (GAPDH,GFP, andNeoR), mRNA specifically associated with an75 kDa protein that was immunopositive for FMRP. Asterisk indicates an artifact of
gel transfer.
(B) NOS1 (green), FMRP (red), and DAPI (blue) staining of 20 PCW FOp. FMRP was coexpressed by L5 columnar NOS1+ pyramidal neurons (solid arrowheads),
but not most interneurons (arrows).
(C and D) FMRP immunoprecipitated mRNAs from a 21 PCW human and P0 mouse CP were analyzed by quantitative RT-PCR. Relative to control GAPDH and
MAP1B mRNAs, FMRP strongly associated with NOS1 mRNA (green bar) in human, but not mouse. Error bars represent the 5th and 95th percentiles of four
measurements.
See also Figure S4.presence of potassium, which facilitates GQ formation, but not
lithium, which abrogates it. Therefore, FMRP interacts with
GQ-forming sequences found within the coding region of human
NOS1 mRNA.
Evolution of NOS1 mRNA GQ-Containing Sequences
To investigate whether GQ motifs are present in other
mammals, we analyzed the 21 species for which NOS1
mRNA sequence was available. Highly stable tetrads at both
GQ1 and GQ2 positions were predicted only in the great apes
and macaque monkey (Figure S5A). Among great apes, which
otherwise have perfectly conserved GQs, only orangutan has
a point mutation that leads to a less stable two-stack GQ1
quartet, but a fully conserved GQ2 quartet. In marmoset, a
New World monkey, and nonprimate mammals, with the excep-
tion of the guinea pig that exhibited one quartet, they are
absent from both positions. Further analysis of the entire
NOS1 coding region in nine placental mammals revealed a
very high degree of conservation (Figure S5B), with the vastmajority of substitutions being synonymous. The few nonsynon-
ymous substitutions, however, were selectively clustered in the
GQ region. This marked reduction in amino acid identity in an
otherwise highly conserved protein is consistent with the
hypothesis that the sequences containing the GQ motifs
evolved and made possible posttranscriptional regulation by
FMRP. Furthermore, these sequences have remained quite
stable since their emergence in catarrhine primates, which is
consistent with the expression of NOS1 in human and macaque
pyramidal neurons.
FMRP Increases NOS1 Expression via Interaction
with a GQ-Containing Sequence
To test the functional consequences of FMRP on NOS1 transla-
tion, we cotransfected human expression constructs of FMRP
(CAG-hFMR1) and NOS1 (CAG-hNOS1) into Neuro-2a cells
and quantified NOS activity (Figure 6E). With CAG-hFMR1 co-
transfection, NOS1 activity was increased in a dose-dependent
manner, by up to 3.6- ± 0.9-fold (p = 0.043), indicating thatCell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc. 905
GATGGGGCCTCGGGTCCCGGGAATGGGCCTCA      AGTGGGAGCAGAGGGGTCAAGGGAGGGGCACC
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Figure 6. FMRP Binds Human NOS1 GQ-Containing Sequences and Enhances Human, but Not Mouse, NOS1 mRNA Translation
(A) Prediction of putative FMRP-binding GQ and U-rich (UR) motifs in the human NOS1 mRNA sequence and alignment of GQ1 and GQ2. GQ1 and GQ2 were
highly conserved in primates, but not rodents.
(B) FMRP association with each putative binding motif was analyzed by an mRNA pull-down assay using 21 PCW human neocortex lysates. FMRP selectively
associated with GQ1 and GQ2.
(C) EMSA of GQ1 and GQ2. RNA containing both GQs exhibited a significant shift in mobility in the presence of FMRP. This shift was abolished by addition of
excess unbiotinylated (‘‘cold’’) RNA or a neutralizing anti-FMRP antibody.
(D) Reverse-transcription termination assay. Reverse transcription paused at the expectedGQ sites for both GQ1 andGQ2 in the presence of K+, which facilitates
GQ formation, but not Li+, which disrupts it.
(E) Colorimetric NOS assays in Neuro-2a cells cotransfected with CAG-hFMR1 or CAG-hFMR1(I304N) and one of CAG-hNOS1, CAG-mNos1, or CAG-murinized-
hNOS1. NOS activity from hNOS1, but not mNos1 or murinized hNOS1, increased dose dependently with increasing wild-type FMRP. The I304N mutation in
FMRP abolished its activation of hNOS1 translation. *p < 0.05. Error bars represent the 5th and 95th percentiles of four measurements.
(F) Luciferase assays in Neuro-2a cells transfected with an empty reporter construct (GL3-empty), or constructs containing the human NOS1 GQs (GL3-
hNOS1[GQs]) or the orthologous sequence in mouse Nos1 (GL3-mNOS1[GQortholog]). Luciferase activity in cells transfected with GL3-hNOS1(GQs) increased
dose dependently with cotransfection of human CAG-hFMR1 (solid blue line) or mouse CAG-mFmr1 (broken blue line). Luciferase activity from the GL3-mNos1
(GQortholog) decreased with increasing amounts of CAG-hFMR1 (solid red line). Error bars represent the 5th and 95th percentiles of six measurements.
See also Figure S5.FMRP acts as a positive regulator of NOS1 expression. No
increase in NOS1 activity occurred when a mouse Nos1
construct (CAG-mNos1) or a human FMR1 construct harboring
the I304N mutation (CAG-hFMR1 [I304N]) (Siomi et al., 1994)
was used, or when the GQ-containing sequence of the human
NOS1 was replaced with the orthologous sequence from mouse
Nos1 (CAG-murinized-hNOS1). Therefore, the FMRP-mediated
increase in NOS1 expression is dependent on the species of
the NOS1 sequence, the intact KH2 domain of FMRP, and the906 Cell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc.presence of GQ-containing sequences in the NOS1 mRNA. To
specifically examine the GQ region, we cloned the NOS1
sequences containing GQ1 and GQ2 into the 30 UTR of
SV40-GL3 and performed luciferase assays in Neuro-2a cells
(Figure 6F). The inclusion of the human NOS1 GQs (SV40-
GL3-hNOS1-GQs) led to significant dose-dependent increases
in luciferase activity in response to CAG-hFMR1, indicating
that FMRP increases NOS1 translation via binding to these
sequences. Importantly, a mouse FMRP expression construct
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Figure 7. Efficient Translation of Human NOS1 in Pyramidal Neurons Requires FMRP and Is Severely Reduced in Fetal FXS Neocortex
(A–C) Neocortex of wild-type or Fmr1 KOmouse electroporated in utero at E13.5 and immunostained for NOS1 (red) at P0. In wild-type neocortex the majority of
pyramidal neurons transfected with hNOS1 expressed high levels of NOS1 properly localized to the soma and apical dendrite. NOS1 protein expression from
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percentiles. Error bars represent the 5th and 95th percentiles of at least four animals.
(D) Immunoblots of human fetal FXS and P0 mouse Fmr1 KO neocortex. Normalized to GAPDH levels, the neocortical expression of NOS1 protein was severely
reduced in both human fetal FXS cases. In neonatal mouse neocortex, loss of Fmr1 did not alter neocortical NOS1 expression.
See also Figure S6.(CAG-mFmr1) dose dependently increased luciferase expres-
sion in a manner highly similar to CAG-hFMR1. However, when
the human NOS1 GQ sequences were replaced with the
orthologous region of the mouse Nos1 (SV40-GL3-mNos1-
GQortholog), FMRP failed to enhance luciferase activity. These
results indicate that FMRP activates NOS1 protein expression
via binding to a sequence containing GQ motifs and that
this interaction exhibits species differences. Together, these
data strongly support a scenario wherein FMRP activation of
NOS1 translation evolved through NOS1 nucleotide substitu-
tions that gave rise to a GQ-containing sequence targeted by
FMRP.Mouse Pyramidal Neurons Efficiently Translate Human
NOS1 in an FMRP-Dependent Manner
Because mouse FMRP is able to enhance human NOS1 expres-
sion, we hypothesized that exogenous human NOS1mRNA can
be efficiently translated in mouse pyramidal neurons, likely in an
Fmr1-dependent manner. To test this in vivo, we introduced
a NOS1 expression construct with the CAG-Gfp reporter into
mouse neocortical ventricular zone (VZ) using in utero electro-
poration (IUE) at E13.5 to target L5 pyramidal neurons. At
P0, the majority of CAG-hNOS1-electroporated L5 pyramidal
neurons expressed NOS1 protein at high levels (Figures 7A–
7C). In contrast those electroporated with CAG-mNos1 orCell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc. 907
CAG-murinized-hNOS1 expressed only low levels of NOS1 in
aminority of neurons, indicating reduced protein expression effi-
ciency consistent with our in vitro assays. Human and mouse
NOS1 exhibited similar somatodendritic localization (Figures
7A and 7B). Therefore, our results show that mouse pyramidal
neurons possess all of the cellular machinery necessary for the
translation of human NOS1 protein and suggest that their dimin-
ished expression of endogenous NOS1 is a result of differences
in the NOS1 mRNA sequence between human and mouse.
To assess FMRP dependence, we further electroporated
Fmr1 knockout (KO) mice with CAG-hNOS1 and CAG-Gfp
(Figure 7A). Both the number of GFP+ neurons expressing
NOS1 and the levels of NOS1 protein decreased significantly
compared to wild-type (Figures 7B and 7C). In addition,
neurons cultured from E14.5 Fmr1 KO and transfected with
CAG-hNOS1 also exhibited a significant reduction in NOS1
levels compared to control (Figure S6A; 43.8% ± 7.8% reduc-
tion; p = 0.0065). These data show that FMRP is required for
the efficient expression of human NOS1 protein in pyramidal
neurons.
Severe Reduction in NOS1 Protein Levels in Developing
Human FXS but Not Mouse Fmr1 KO Neocortex
To determine whether NOS1 protein levels are altered in human
FXS cases, we performed immunoblotting of neocortex from
confirmed midfetal and postnatal FXS cases (15 and 18 PCW;
and 9, 22, and 85 years) and age-matched controls. Neocortical
lysates normalized to GAPDH levels were immunoblotted for
NOS1, FMRP, and GAPDH (Figure 7D). Remarkably, in both fetal
cases of FXS, neocortical NOS1 protein levels were severely
reduced compared to matched controls. Furthermore, this
deficit was age dependent, being very dramatic in the fetal
cases, less so in the cases aged 9 and 22 years, and absent in
the 85 years’ specimen (Figure S6C). These results indicate
that NOS1 protein expression is greatly reduced in the devel-
oping human FXS neocortex. Notably, neocortical NOS1 levels
were not affected in early postnatal Fmr1 KO mice (Figures 7D
and S6B), indicating that the requirement of FMRP for NOS1
expression is species dependent.
DISCUSSION
In this study we demonstrate that human neocortical NOS1
expression is posttranscriptionally regulated by FMRP in a
species-dependent manner. Molecular analyses revealed that
FMRP binds GQ motif-containing sequences present in the
coding region of human, but not mouse, NOS1 mRNA and facil-
itates NOS1 protein expression. Concordantly, NOS1 expres-
sion is severely reduced in the developing FXS human, but not
FMRP-deficient mouse, neocortex. In the human neocortex,
NOS1 and FMRP are transiently coexpressed during synapto-
genesis in subpopulations of pyramidal neurons in regions
involved in speech, language, and complex social behaviors.
Together, these findings provide a novel candidate mechanism
and insights into the potential connectional pathology of FXS
and possibly ASD.
Our analyses indicate that the FMRP-NOS1 interaction
emerged as result of closely clustered nucleotide substitutions908 Cell 149, 899–911, May 11, 2012 ª2012 Elsevier Inc.within the otherwise highly conserved coding sequence of
NOS1 that gave rise to the GQ-containing motifs, occurring at
the potential expense of protein integrity. FMRP binding to GQ
motifs has been associated with translational repression
(Bechara et al., 2009; Schaeffer et al., 2001). There is, however,
a precedent for positive, activity-dependent posttranscriptional
regulation in PSD-95 (DLG4), which has an FMRP-binding GQ
motif (Todd et al., 2003; Zalfa et al., 2007). Interestingly, NOS1
and PSD-95 are functionally related. NOS1 is anchored to the
synaptic membrane via a physical interaction with PSD-95
(Brenman et al., 1996) and its enzymatic product, NO, S-nitrosy-
lates PSD-95 (Ho et al., 2011). Although the abundant presence
of NOS1mRNA in pyramidal neurons suggests that translational
regulation is involved, FMRP may also control the stability of the
NOS1 transcript in a manner similar to its control of PSD-95
mRNA stability (Zalfa et al., 2007). Furthermore, the GQ motif
has been shown to mediate the dendritic localization of
PSD-95 (Dictenberg et al., 2008) and may also play a role in
NOS1 mRNA targeting. The possibility that NOS1 and PSD-95
are similarly regulated by FMRP is consistent with their shared
postsynaptic localization, physical interaction, and related func-
tions. The binding of FMRP to GQs has been demonstrated both
in vitro (Bagni and Greenough, 2005; Bassell and Warren, 2008)
and in vivo (Rackham and Brown, 2004; Iioka et al., 2011).
Recently, however, it was shown that the presence GQ motifs
is not predictive of FMRP binding (Darnell et al., 2011). Therefore,
the context dependence of FMRP interactions with GQs remains
to be fully elucidated, and individual potential interactions should
be validated empirically.
Animal models of FXS exhibit multiple phenotypes present in
human FXS, indicating that many aspects of FMRP function
are well conserved. Therefore, any contribution of NOS1 to the
FXS phenotype would likely involve the higher cognitive func-
tions that are absent from mouse. This possibility is supported
by the coexpression of NOS1 and FMRP in projection neurons
of the FOp and the ACC and adjacent dorsal frontoparietal
neocortex. The FOp encompasses the future Broca’s area and
its contralateral hemisphere equivalent, as well as the orofacial
motor cortex, regions involved in speech production, language
comprehension, and action recognition (Keller et al., 2009).
The ACC is involved in decision making, attention, emotional
processing, and social awareness (Devinsky et al., 1995).
NOS1 expression in these regions is also temporally regulated
from midgestation to early infancy, a developmental period crit-
ical for early synaptogenesis, dendritic spine formation, and
ingrowth of cortical afferents (Kang et al., 2011). Therefore, the
neuroanatomical localization and timing of the FMRP-NOS1
interaction are consistent with a putative role in the development
of neocortical circuits, including those involved in linguistic and
social functions likely affected in FXS and ASD.
This potential role of NOS1 in the development and function of
human neural circuits is further supported by studies of a human
NOS1 hypomorphic allele, which has been associated with
attention deficit hyperactivity disorder (ADHD), impulsivity, and
aggression (Reif et al., 2009), behavioral features often comorbid
with FXS (Rogers et al., 2001). This NOS1 hypomorphism has
also been associated with hypoactivity in the ACC (Reif et al.,
2009), a cortical region with prominent midfetal pyramidal
expression of NOS1 protein. Functional imaging studies re-
vealed a similar reduction in ACC activation in patients with
FXS and ADHD during attentional-processing tasks (Bush
et al., 1999; Menon et al., 2004) and in autistic children in
response to a familiar face (Pierce and Redcay, 2008). The over-
lapping deficits between NOS1 hypomorphism, FXS, and FXS
comorbidities are consistent with a functional role of NOS1 in
human brain circuitry related to FXS and ASD. Furthermore,
the two midfetal neocortical regions with prominent pyramidal
NOS1 expression, the ACC and FOp, exhibit highly coordinated
resting state activity, suggesting functional connectivity between
the two areas and the presence of a cingulo-opercular cognitive
network (Power et al., 2011). Interestingly, the connectivity of this
cingulo-opercular network has been reported to be impaired in
schizophrenia (Tu et al., 2012). Remarkably, multiple sequence
variations in NOS1 have been associated with schizophrenia
(Cui et al., 2010; Reif et al., 2006; Shinkai et al., 2002), supporting
a potential role of NOS1 in the formation of cognitive circuits and
in disorders that affect cognition.
Structural alteration in the organization of minicolumns has
been reported in autism and other psychiatric disorders (Casa-
nova et al., 2002). In this study we found that within the midfetal
FOp, alternating L5 columns coexpress FMRP and NOS1, as
well as FOXP2, which is implicated in the development of
speech, language, and cognition (Lai et al., 2001), functions
affected in FXS and ASD. We also showed that neurons within
the same column have a shared subcortical molecular identity
and connectivity. Positioned in between the columns are migra-
tory corridors containing radial glial fibers and corticocortical
projection neurons en route to the superficial layers. Thus, this
fetal organization may have implications for the developmental
basis of normal minicolumns (Rakic, 1988), as well as columno-
pathies (Casanova et al., 2002). Interestingly, the NOS1+
columnar neurons of the fetal FOp share some areal and projec-
tion properties with adult mirror neurons, which are present in
macaque area F5 (Rizzolatti and Craighero, 2004), an area equiv-
alent to the human Broca’s area, and project subcortical axons
(Kraskov et al., 2009). Mirror neurons, which are activated during
both the observation and execution of a particular goal-directed
action, are thought to contribute to theory of mind and language
abilities (Rizzolatti and Craighero, 2004), and in autistic children
the mirror neuron activity that is normally observed in the FOp
is absent (Dapretto et al., 2006). Therefore, the molecular profile
of NOS1+ columns, as well as their shared location and connec-
tivity with mirror neurons, is consistent with a potential role in
motor and cognitive development.
The synthesis of NO, a short-lived gas that cannot be stored or
transported, must be precisely regulated and amenable to rapid,
localized activation. Because FMRP controls both the dendritic
localization and translation of target mRNAs, it is well suited to
contribute to the dynamic regulation of NOS1 activity. It should
be noted, however, that NOS1 mRNA may also be under addi-
tional, perhaps negative, posttranscription control, as suggested
by the lack of NOS1 protein expression in the majority of NOS1
mRNA-expressing pyramidal neurons. The modulation of
neuronal function by NO in the brain has been widely studied,
and postsynaptic NO is thought to represent a retrograde signal
that promotes presynaptic differentiation (Bredt and Snyder,1994; Garthwaite, 2008). Blockade of NOS1 function has been
shown to disrupt synapse formation and result in spine loss
(Nikonenko et al., 2008). Given the potential role of NO in
synapse development, the loss of NOS1 expression in the fetal
FXS brain during early synaptogenesis may contribute to the
dendritic spine phenotype of human FXS (Irwin et al., 2000).
Studies have also shown that NO mediates neuronal synchroni-
zation (O’Donnell and Grace, 1997) and can modulate protein
function via S-nitrosylation (Jaffrey et al., 2001), including that
of histones (Nott et al., 2008), which can mediate transcriptome
changes. In future studies it will be important to characterize the
mechanisms of NO function in the developing human neocortex
and their potential contribution to FXS.
EXPERIMENTAL PROCEDURES
Human Brain Tissue Processing
The sources and methods for the collection, dissection, and fixation of control
and fragile X postmortem human tissues are described in the Extended Exper-
imental Procedures. All specimens were collected under guidelines approved
by institutional review boards and anonymized prior to our receipt. Fixed
tissues were sectioned by vibratome or cryostat. For NADPH-d staining,
sections were incubated in b-NADPH, nitro blue tetrazolium, and Triton
X-100. Sections were preincubated in hydrogen peroxide for immunohisto-
chemistry or directly preblocked in blocking solution for immunofluorescent
staining prior to incubation with primary antibodies followed by biotinylated
or fluorophore-conjugated secondary antibodies. For immunohistochemistry,
sections were further incubated in avidin-biotin-peroxidase complex and
visualized using DAB.
RNA Pull-Down Assay and RIP
For pull-down assays, RNAs were transcribed from cDNA or PCR products,
biotinylated, and captured using streptavidin beads. Human midfetal CP
lysates were added, and bound proteins were analyzed by SDS-PAGE, silver
staining, and immunoblotting. For RIP, FMRP-bound mRNAs were immuno-
precipitated from midfetal human and neonatal mouse CP lysates and
analyzed using quantitative RT-PCR.
Expression Assays and IUE
The generation of DNA constructs is described in the Extended Experimental
Procedures. Neuro-2a cells were transfected by lipofection. Luciferase or NOS
activity was assayed 48 hr after transfection and normalized to transfection
efficiency controls. For electroporation, DNA was injected into the lateral
ventricles of embryonic mice and transferred into VZ cells by 40V pulses. Elec-
troporated brains were analyzed at P0 by immunostaining. All experiments
using animals were carried out in accordance with a protocol approved by
Yale University’s Committee on Animal Research and National Institutes of
Health guidelines.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.cell.
2012.02.060.
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